Skip to main content

Medikamenteninduzierter Dauerkopfschmerz

  • Chapter
Migräne

Zusammenfassung

Jeder Arzt, der sich mit Kopfschmerzpatienten beschäftigt, kennt den berüchtigten Kranken, der das Sprechzimmer betritt und auf die Frage, welches Problem er habe, antwortet: „Ich habe jeden Tag Kopfschmerzen“. Zwei weitere Fragen und Antworten darauf klären dann bereits die Diagnose. Die erste Frage lautet: „Was machen Sie gegen Ihre Kopfschmerzen?“, die dazugehörige Antwort: „Ich nehme Schmerzmittel“. Die nächste Frage lautet: „Wie häufig nehmen Sie Schmerzmittel?“, darauf die eindeutige Antwort des Patienten: „Jeden Tag!“

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ala-Hurula V, Myllylae V, Hokkanen E (1982) Ergotamine abuse: results of ergotamine discontinuadon, with special reference to the plasma concentradons. Cephalalgia 2:189–195

    Article  PubMed  CAS  Google Scholar 

  2. Baumgartner C, Wessely P, Bingöl C, Maly J, Holzner F (1989) Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches. Headache 29:510–514

    Article  PubMed  CAS  Google Scholar 

  3. Dichgans J, Diener HC (1988) Clinical manifestations of excessive use of analgesic medication. In: Diener HC, Wilkinson M (eds) Drug-induced headache. Springer Berlin Heidelberg New York Tokyo, pp 8–15

    Chapter  Google Scholar 

  4. Dichgans J, Diener HC, Gerber WD, Verspohl EJ, Kukiolka H, Kluck M (1984) Analgetika-induzierter Dauerkopfschmerz. Dtsch Med Wochenschr 109:369–373

    Article  PubMed  CAS  Google Scholar 

  5. Diener HC, Bühler K-U, Dichgans J, Geiselhart S, Gerber WD, Scholz E (1988) Analgetikainduzierter Dauerkopfschmerz. Existiert eine kridsche Dosis? Arzneimitteltherapie 6:156–164

    Google Scholar 

  6. Diener HC, Gerber WD, Geiselhart D, Dichgans J, Scholz E (1988) Short and long term effects of withdrawal therapy in drug-induced headache. In: Diener HC, Wilkinson M (eds) Drug-induced headache. Springer Berlin Heidelberg New York Tokyo, pp 133–142

    Chapter  Google Scholar 

  7. Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber WD, Bihe A (1989) Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol 236:9–14

    Article  PubMed  CAS  Google Scholar 

  8. Diener HC, Haab J, Peters C, Ried S, Dichgans J, Pilgrim A (1990) Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 31:205–209

    Article  Google Scholar 

  9. Diener HC, Pfaffenrath V, Soyka D, Gerber WD (1992) Therapie des medikamenteninduzierten Dauerkopfschmerzes. — Empfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. MMW 134:159–162

    Google Scholar 

  10. Dige-Petersen H, Lassen NA, Noer J, Toennesen KH, Olesen J (1977) Subclinical ergodsm. Lancet 11:65–66

    Article  Google Scholar 

  11. Gerber WD, Miltner W, Niederberger U (1988) The role of behavioral and social factors in the development of drug-induced headache. In: Diener HC, Wilkinson M (eds) Drug-induced headache. Springer Berlin Heidelberg New York Tokyo, pp 65–74

    Chapter  Google Scholar 

  12. Gutzwiller F, Zemp E (1986) Der Analgetikakonsum in der Bevölkerung und sozioökonomische Aspekte des Analgetikaabusus. In: Mihatsch MJ (Hrsg) Das Analgetikasyndrom. Thieme Stuttgart, S 197–205

    Google Scholar 

  13. Headache Classification Committee of the Intemational Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia [Suppl 7] 8:1–93

    Google Scholar 

  14. Henry P, Daubech JF, Lucas J, Gagnon M (1988) Dependence of analgesic medication in chronic headache sufferers: psychological analysis. In: Diener HC, Wilkinson M (eds) Drug-induced headache. Springer Berlin Heidelberg New York Tokyo, pp 75–79

    Chapter  Google Scholar 

  15. Horton BT, Peters GA (1963) Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache 3: 214–226

    Article  Google Scholar 

  16. Isler H (1982) Migraine treatment as a cause of chronic migraine. In: Clifford Rose F (ed) Advances in migraine research. Raven Press, New York, pp 159–164

    Google Scholar 

  17. Kudrow L (1982) Paradoxical effects of frequent analgesic use. In: Critchley M, Fridman AP, Gorini S, Sicuteri F (eds). Advances in neurology, vol 33. Raven Press New York, pp 335–341

    Google Scholar 

  18. Ludolph AC, Husstedt IW, Schlake HP, Grotemeyer KH, Brune GG (1988) Chronic ergotamine abuse: evidence of functional impairment of long ascending spinal tracts. Eur Neurol 28:311–316

    Article  PubMed  CAS  Google Scholar 

  19. Mathew NT (1988) Amelioration of ergotamine withdrawal symptoms with the use of nonsteroidal anti-inflammatory agent naproxen. In: Diener HC, Wilkinson M (eds) Drug-induced headache. Springer Berlin Heidelberg New York Tokyo, pp 150–156

    Chapter  Google Scholar 

  20. Micieli G, Manzoni GC, Granella F, Martignoni E, Malferrari G, Nappi G (1988) Clinical and epidemiological observations on drug abuse in headache patients. In: Diener HC, Wilkinson M (eds) Drug-induced headache. Springer Berlin Heidelberg New York Tokyo, pp 20–28

    Chapter  Google Scholar 

  21. Mihatsch MJ (1986) Das Analgetikasyndrom. Thieme Stuttgart New York

    Google Scholar 

  22. Mihatsch MJ, Hofer HO, Gutzwiller F, Bmnner FP, Zollinger HU (1980) Phenacetinabusus. I. Häufigkeit, Pro-Kopf-Verbrauch und Folgekosten. Schweiz Med Wochenschr 110:108–115

    PubMed  CAS  Google Scholar 

  23. Pfaffenrath V, Niederberger U (1988) What kind of dmgs are taken by patients with primary headaches. In: Diener HC, Wilkinson M (eds) Drug-induced headache. Springer Berlin Heidelberg New York Tokyo, pp 44–64

    Chapter  Google Scholar 

  24. Rowsell AR, Neylan C, Wilkinson M (1973) Ergotamine induced headaches in migrainous patients. Headache 13:65–67

    Article  PubMed  CAS  Google Scholar 

  25. Saper JR (1988) Daily chronic headache — tension headaches, migraine, and combined headaches. The transformation concept. In: Diener HC, Wilkinson M (eds) Drug-induced headache. Springer Berlin Heidelberg New York Tokyo, pp 5–8

    Chapter  Google Scholar 

  26. Spühler O, Zollinger HU (1950) Die chronisch interstiüelle Nephrins. Helv Med Acta 17:564–567

    PubMed  Google Scholar 

  27. Tfelt-Hansen P (1988) Clinical pharmacology of ergotamine. An overview. In: Diener HC, Wilkinson M (eds) Drug-induced headache. Springer Berlin Heidelberg New York Tokyo, pp 105–116

    Chapter  Google Scholar 

  28. Wörz R (1983) Effects and risks of psychotropic and analgesic combinations. Am J Med 75:139–140

    Article  PubMed  Google Scholar 

  29. Zschiedrich M, Heidrich H, Dienes HP (1985) Ergotismus: Epidemiologie, Pathogenese, Histomorphologie, Diagnostik und Therapie. Med Klin 80:721–727

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Diener, HC. (1994). Medikamenteninduzierter Dauerkopfschmerz. In: Ensink, F.B.M., Soyka, D. (eds) Migräne. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-93522-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-93522-0_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-93523-7

  • Online ISBN: 978-3-642-93522-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics